These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 15193918

  • 1. Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera.
    Chikhlikar P, Barros de Arruda L, Agrawal S, Byrne B, Guggino W, August JT, Marques ET.
    Virology; 2004 Jun 01; 323(2):220-32. PubMed ID: 15193918
    [Abstract] [Full Text] [Related]

  • 2. HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses.
    Marques ET, Chikhlikar P, de Arruda LB, Leao IC, Lu Y, Wong J, Chen JS, Byrne B, August JT.
    J Biol Chem; 2003 Sep 26; 278(39):37926-36. PubMed ID: 12824194
    [Abstract] [Full Text] [Related]

  • 3. West Nile premembrane-envelope genetic vaccine encoded as a chimera containing the transmembrane and cytoplasmic domains of a lysosome-associated membrane protein: increased cellular concentration of the transgene product, targeting to the MHC II compartment, and enhanced neutralizing antibody response.
    Anwar A, Chandrasekaran A, Ng ML, Marques E, August JT.
    Virology; 2005 Feb 05; 332(1):66-77. PubMed ID: 15661141
    [Abstract] [Full Text] [Related]

  • 4. A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV.
    Xin KQ, Ooki T, Jounai N, Mizukami H, Hamajima K, Kojima Y, Ohba K, Toda Y, Hirai S, Klinman DM, Ozawa K, Okuda K.
    J Gene Med; 2003 May 05; 5(5):438-45. PubMed ID: 12731092
    [Abstract] [Full Text] [Related]

  • 5. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD, Wang S, Caskey MS, Unangst T, Hocker L, He L, Hudacik L, Whitney S, Keen T, Chou TH, Shen S, Joshi S, Kalyanaraman VS, Nair B, Markham P, Lu S, Pal R.
    Virology; 2006 Mar 01; 346(1):151-68. PubMed ID: 16325880
    [Abstract] [Full Text] [Related]

  • 6. [Immune response induced by HIV DNA vaccine combined with recombinant adeno-associated virus].
    Liu YZ, Zhou L, Wang Q, Ye SQ, Li HX, Zeng Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep 01; 18(3):251-4. PubMed ID: 15640860
    [Abstract] [Full Text] [Related]

  • 7. Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice.
    Goldoni AL, Maciel M, Rigato PO, Piubelli O, de Brito CA, Melo A, Marques ET, August JT, Duarte AJ, Sato MN.
    Immunobiology; 2011 Apr 01; 216(4):505-12. PubMed ID: 20870310
    [Abstract] [Full Text] [Related]

  • 8. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S, Feng X, Shu T, Matano T, Hasegawa M, Wang X, Ma H, Li H, Li Z, Zeng Y.
    Vaccine; 2008 Nov 11; 26(48):6124-31. PubMed ID: 18812199
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of DNA vaccine-induced immune responses by a 72-bp element from SV40 enhancer.
    Li HS, Liu Y, Li DF, Zhang RR, Tang HL, Zhang YW, Huang W, Liu Y, Peng H, Xu JQ, Hong KX, Shao YM.
    Chin Med J (Engl); 2007 Mar 20; 120(6):496-502. PubMed ID: 17439744
    [Abstract] [Full Text] [Related]

  • 10. [Immune potency of recombinant adeno-associated virus combined with recombinant adenovirus vaccine containing HIV-1 gp120].
    Feng X, Yu SQ, Chen GM, Wu XB, Zuo JM, Dong WP, Zhou L, Zeng Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec 20; 18(4):312-5. PubMed ID: 15650777
    [Abstract] [Full Text] [Related]

  • 11. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
    Park JY, Jin DH, Lee CM, Jang MJ, Lee SY, Shin HS, Chung YH, Kim KY, Kim SS, Lee WB, Shin YK, Lee WJ, Park YM, Kim D.
    J Immunother; 2010 Jun 20; 33(5):510-22. PubMed ID: 20463596
    [Abstract] [Full Text] [Related]

  • 12. Immunization of neonatal mice with LAMP/p55 HIV gag DNA elicits robust immune responses that last to adulthood.
    Rigato PO, Maciel M, Goldoni AL, Piubelli O, de Brito CA, Fusaro AE, Eurico de Alencar LX, August T, Azevedo Marques ET, da Silva Duarte AJ, Sato MN.
    Virology; 2010 Oct 10; 406(1):37-47. PubMed ID: 20667577
    [Abstract] [Full Text] [Related]

  • 13. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W, Ren L, Jin N.
    J Virol Methods; 2007 Dec 10; 146(1-2):266-73. PubMed ID: 17868910
    [Abstract] [Full Text] [Related]

  • 14. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.
    Deml L, Bojak A, Steck S, Graf M, Wild J, Schirmbeck R, Wolf H, Wagner R.
    J Virol; 2001 Nov 10; 75(22):10991-1001. PubMed ID: 11602739
    [Abstract] [Full Text] [Related]

  • 15. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE, Zhang J, Whitton JL.
    Virology; 1999 Oct 10; 263(1):175-83. PubMed ID: 10544092
    [Abstract] [Full Text] [Related]

  • 16. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
    Zhao HP, Sun JF, Li N, Sun Y, Wang Y, Qiu HJ.
    Vet Immunol Immunopathol; 2009 Oct 15; 131(3-4):158-66. PubMed ID: 19411115
    [Abstract] [Full Text] [Related]

  • 17. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
    Akahata W, Yang ZY, Nabel GJ.
    J Virol; 2005 Jan 15; 79(1):626-31. PubMed ID: 15596858
    [Abstract] [Full Text] [Related]

  • 18. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M.
    Virus Res; 2006 Mar 15; 116(1-2):11-20. PubMed ID: 16214252
    [Abstract] [Full Text] [Related]

  • 19. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
    Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS.
    Virology; 2001 Nov 10; 290(1):74-82. PubMed ID: 11883007
    [Abstract] [Full Text] [Related]

  • 20. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C, Rogers WO, Gowda K, Doolan DL.
    Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.